Clinical Trials Directory

Trials / Conditions / Protein Kinase Inhibitors

Protein Kinase Inhibitors

7 registered clinical trials studyying Protein Kinase Inhibitors — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingSingle vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB
NCT06535568
Fondazione Ricerca e Innovazione Cardiovascolare ETSN/A
RecruitingPhase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
NCT06128148
Guangzhou JOYO Pharma Co., LtdPhase 1
Terminated(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
NCT05153408
Blueprint Medicines CorporationPhase 1
Terminated(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
NCT04862780
Blueprint Medicines CorporationPhase 1
CompletedTACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
NCT04518852
Sichuan Cancer Hospital and Research InstitutePhase 2
Active Not RecruitingSavolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192
AstraZenecaPhase 3
CompletedA Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced
NCT00676299
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 1